Launch of new interactive Non-small Cell Lung Cancer resource for physicians
| by EPG Health Media | July 24, 2008
London, England, 24th July, 2008
Launch of new interactive Non-small Cell Lung Cancer resource for physicians
EPG Health Media, developers of e-communication and clinical information solutions for the health sector, today announced the launch of a new interactive Non-small Cell Lung Cancer Knowledge Centre within the web-based physician resource www.epgonline.org.
Sanctioned by the European Medical Association (EMA), EPG Online is a free service dedicated to providing Health Care Professionals (HCPs) with up to date access to best practice diagnosis and patient management guidance. This independent service provides access to a range of EU pharmaceutical drug information, disease Knowledge Centers, decision support tools and original medical news content.
The Non-Small Cell Lung Cancer Knowledge Centre has been sponsored by F.Hoffmann-La Roche and will broaden the range of existing interactive guides that form part of the EPG Online disease knowledge library. Other guides focus on subjects such as Alzheimers Disease, Benign Prostatic Hyperplasia, ADHD, Parkinsons Disease, Parkinson s disease, Migraine, Cervical Cancer, Renal Anaemia and Hypertension.
During 2008 we will introduce a series of new Oncology disease Knowledge Centres intended to satisfy growing HCP demand for greater depth and quality of online research and educational resources said Chris Cooper, Managing Director of EPG Health Media.
The Non-Small Cell Lung Cancer Knowledge Centre contains practical information on causes, risk factors, symptoms and diagnosis of the disease, as well as advice on treatment strategies for the various stages, including chemotherapy, surgery and radiotherapy.
This new Knowledge Centre will not only satisfy a known appetite from our users for information on this disease area but will also help them arrive at a more confident diagnosis and more effective treatment strategies for their patients Chris Cooper stated. We are grateful to Roche for their support of our services and their shared vision, working with us to communicate important clinical information to our ever growing audience.
EPG Online also provides access to drug databases, safety alerts, drug reviews, evidence based commentary and findings, medical news and journal abstracts. The service is funded through pharmaceutical industry sponsorship and educational grants.
About EPG Health Media.
EPG Health Media is owned by UK based IMR International Ltd, a private limited Company specialising in the delivery of e-communication and clinical information solutions. The Companys activities fall within three key areas of competency; electronic publishing, e-Marketing/Communications Solutions and market research.
CONTACT:
EPG Health Media Public Relations
PHONE: (+44) 01892 667512
E-MAIL: press@imrmedia.net
WEB: www.epghealthmedia.com
Launch of new interactive Non-small Cell Lung Cancer resource for physicians
EPG Health Media, developers of e-communication and clinical information solutions for the health sector, today announced the launch of a new interactive Non-small Cell Lung Cancer Knowledge Centre within the web-based physician resource www.epgonline.org.
Sanctioned by the European Medical Association (EMA), EPG Online is a free service dedicated to providing Health Care Professionals (HCPs) with up to date access to best practice diagnosis and patient management guidance. This independent service provides access to a range of EU pharmaceutical drug information, disease Knowledge Centers, decision support tools and original medical news content.
The Non-Small Cell Lung Cancer Knowledge Centre has been sponsored by F.Hoffmann-La Roche and will broaden the range of existing interactive guides that form part of the EPG Online disease knowledge library. Other guides focus on subjects such as Alzheimers Disease, Benign Prostatic Hyperplasia, ADHD, Parkinsons Disease, Parkinson s disease, Migraine, Cervical Cancer, Renal Anaemia and Hypertension.
During 2008 we will introduce a series of new Oncology disease Knowledge Centres intended to satisfy growing HCP demand for greater depth and quality of online research and educational resources said Chris Cooper, Managing Director of EPG Health Media.
The Non-Small Cell Lung Cancer Knowledge Centre contains practical information on causes, risk factors, symptoms and diagnosis of the disease, as well as advice on treatment strategies for the various stages, including chemotherapy, surgery and radiotherapy.
This new Knowledge Centre will not only satisfy a known appetite from our users for information on this disease area but will also help them arrive at a more confident diagnosis and more effective treatment strategies for their patients Chris Cooper stated. We are grateful to Roche for their support of our services and their shared vision, working with us to communicate important clinical information to our ever growing audience.
EPG Online also provides access to drug databases, safety alerts, drug reviews, evidence based commentary and findings, medical news and journal abstracts. The service is funded through pharmaceutical industry sponsorship and educational grants.
About EPG Health Media.
EPG Health Media is owned by UK based IMR International Ltd, a private limited Company specialising in the delivery of e-communication and clinical information solutions. The Companys activities fall within three key areas of competency; electronic publishing, e-Marketing/Communications Solutions and market research.
CONTACT:
EPG Health Media Public Relations
PHONE: (+44) 01892 667512
E-MAIL: press@imrmedia.net
WEB: www.epghealthmedia.com
Article Source: http://www.articleset.com

You are welcome to publish or reprint this article free of charge, provided:
- you include the entire article, unchanged, including the "About The Author" box
- all hyperlinks remain active, including the bottom ArticleSet.com link (does not apply to print publications)
- you agree not to hold the authors nor ArticleSet.com liable for any loss profits, expenses, or any other damages resulting from the use or misuse of articles published on this website